{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T06:00:14Z","timestamp":1787032814341,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,24]]},"DOI":"10.7759\/cureus.104209","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:46:07Z","timestamp":1772001967000},"source":"Crossref","is-referenced-by-count":1,"title":["Transient Mood Elevation Without a Manic Switch: Goldenseal-Augmented Oral Glutamatergic Regimen in Bipolar Depression With Comorbid Obsessive-Compulsive Disorder (OCD)"],"prefix":"10.7759","author":[{"given":"Ngo","family":"Cheung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/archgenpsychiatry.2011.12","article-title":"Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative","volume":"68","author":"Merikangas KR","year":"2011","unstructured":"Merikangas KR, Jin R, He JP, et al.. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry. 2011, 68:241-51. 10.1001\/archgenpsychiatry.2011.12","journal-title":"Arch Gen Psychiatry"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2014.05.026","article-title":"Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review","volume":"166","author":"Amerio A","year":"2014","unstructured":"Amerio A, Odone A, Marchesi C, Ghaemi SN. Treatment of comorbid bipolar disorder and obsessive-compulsive disorder: a systematic review. J Affect Disord. 2014, 166:258-63. 10.1016\/j.jad.2014.05.026","journal-title":"J Affect Disord"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jad.2019.11.136","article-title":"Comorbidity of obsessive-compulsive disorder in bipolar spectrum disorders: Systematic review and meta-analysis of its prevalence","volume":"263","author":"Ferentinos P","year":"2020","unstructured":"Ferentinos P, Preti A, Veroniki AA, Pitsalidis KG, Theofilidis AT, Antoniou A, Fountoulakis KN. Comorbidity of obsessive-compulsive disorder in bipolar spectrum disorders: Systematic review and meta-analysis of its prevalence. J Affect Disord. 2020, 263:193-208. 10.1016\/j.jad.2019.11.136","journal-title":"J Affect Disord"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.2009.01514.x","article-title":"Mania associated with antidepressant treatment: comprehensive meta-analytic review","volume":"121","author":"Tondo L","year":"2010","unstructured":"Tondo L, V\u00e1zquez G, Baldessarini RJ. Mania associated with antidepressant treatment: comprehensive meta-analytic review. Acta Psychiatr Scand. 2010, 121:404-14. 10.1111\/j.1600-0447.2009.01514.x","journal-title":"Acta Psychiatr Scand"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2013.13020185","article-title":"The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders","volume":"170","author":"Pacchiarotti I","year":"2013","unstructured":"Pacchiarotti I, Bond DJ, Baldessarini RJ, et al.. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry. 2013, 170:1249-62. 10.1176\/appi.ajp.2013.13020185","journal-title":"Am J Psychiatry"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2014.13111501","article-title":"The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer","volume":"171","author":"Viktorin A","year":"2014","unstructured":"Viktorin A, Lichtenstein P, Thase ME, Larsson H, Lundholm C, Magnusson PK, Land\u00e9n M. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry. 2014, 171:1067-73. 10.1176\/appi.ajp.2014.13111501","journal-title":"Am J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.focus.20230009","article-title":"The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence","volume":"21","author":"Keramatian K","year":"2023","unstructured":"Keramatian K, Chithra NK, Yatham LN. The CANMAT and ISBD guidelines for the treatment of bipolar disorder: summary and a 2023 update of evidence. Focus (Am Psychiatr Publ). 2023, 21:344-53. 10.1176\/appi.focus.20230009","journal-title":"Focus (Am Psychiatr Publ)"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2462","article-title":"Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders","volume":"7","author":"Sanacora G","year":"2008","unstructured":"Sanacora G, Zarate CA, Krystal JH, Manji HK. Targeting the glutamatergic system to develop novel, improved therapeutics for mood disorders. Nat Rev Drug Discov. 2008, 7:426-37. 10.1038\/nrd2462","journal-title":"Nat Rev Drug Discov"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ijnp\/pyab023","article-title":"Ketamine for bipolar depression: a systematic review","volume":"24","author":"Bahji A","year":"2021","unstructured":"Bahji A, Zarate CA, Vazquez GH. Ketamine for bipolar depression: a systematic review. Int J Neuropsychopharmacol. 2021, 24:535-41. 10.1093\/ijnp\/pyab023","journal-title":"Int J Neuropsychopharmacol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/20451253231202723","article-title":"Ketamine for bipolar depression: an updated systematic review","volume":"13","author":"Fancy F","year":"2023","unstructured":"Fancy F, Haikazian S, Johnson DE, et al.. Ketamine for bipolar depression: an updated systematic review. Ther Adv Psychopharmacol. 2023, 13:20451253231202723. 10.1177\/20451253231202723","journal-title":"Ther Adv Psychopharmacol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17942744","article-title":"Neuroplasticity in bipolar disorder with a ketamine-like glutamatergic regimen: a mechanistic review","author":"Cheung N","year":"2025","unstructured":"Cheung N. Neuroplasticity in bipolar disorder with a ketamine-like glutamatergic regimen: a mechanistic review. Zenodo. 2025, 10.5281\/zenodo.17942744","journal-title":"Zenodo"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18214025","article-title":"From pruned circuits to manic instability: genetic evidence for independent pruning dominance and risk-amplifying cognitive reserve in bipolar disorder","author":"Cheung N","year":"2026","unstructured":"Cheung N. From pruned circuits to manic instability: genetic evidence for independent pruning dominance and risk-amplifying cognitive reserve in bipolar disorder. Zenodo. 2026, 10.5281\/zenodo.18214025","journal-title":"Zenodo"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.18298989","article-title":"Modeling antidepressant-induced manic switch and longitudinal relapse: a unified pruning framework highlights glutamatergics' disease-modifying potential","author":"Cheung N","year":"2026","unstructured":"Cheung N. Modeling antidepressant-induced manic switch and longitudinal relapse: a unified pruning framework highlights glutamatergics' disease-modifying potential. Zenodo. 2026, 10.5281\/zenodo.18298989","journal-title":"Zenodo"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.200600300","article-title":"Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea","volume":"52","author":"Gurley BJ","year":"2008","unstructured":"Gurley BJ, Swain A, Hubbard MA, et al.. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea. Mol Nutr Food Res. 2008, 52:755-63. 10.1002\/mnfr.200600300","journal-title":"Mol Nutr Food Res"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke K","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16:606-13. 10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer RL","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006, 166:1092-7. 10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105085","article-title":"Goldenseal (Hydrastis canadensis L.) and its active constituents: a critical review of their efficacy and toxicological issues","volume":"160","author":"Mandal SK","year":"2020","unstructured":"Mandal SK, Maji AK, Mishra SK, Ishfaq PM, Devkota HP, Silva AS, Das N. Goldenseal (Hydrastis canadensis L.) and its active constituents: a critical review of their efficacy and toxicological issues. Pharmacol Res. 2020, 160:105085. 10.1016\/j.phrs.2020.105085","journal-title":"Pharmacol Res"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/464614-transient-mood-elevation-without-a-manic-switch-goldenseal-augmented-oral-glutamatergic-regimen-in-bipolar-depression-with-comorbid-obsessive-compulsive-disorder-ocd","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:46:08Z","timestamp":1772001968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/464614-transient-mood-elevation-without-a-manic-switch-goldenseal-augmented-oral-glutamatergic-regimen-in-bipolar-depression-with-comorbid-obsessive-compulsive-disorder-ocd"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.104209","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}